Avid Bioservices Inc (CDMO)

[cjgaddy]

Avid Revs FY17(fye 4-30-17) Guidance $60-65mm. I went back 4 prior years – they’re not in the habit of not beating the upper-ends of March Guidances. With Revs for 1st 3qtrs = (5.6 + 23.4 + 10.7) = $39.7mm, if they follow suit, Q4 Revs will be at least (65mm – 39.7) = $25mm.
...How close would that get us to Cash-Flow positive for Q4, should it happen? OP. CASH BURN for Q3(1-31-17) was: $6,274,000.

3-13-17/PR: “Avid Revenue Guidance Increased to $60-65mm for FY’17; Contracted B/L=$70mm”
ACTUAL FY17= $??.?mm (reported ~7-13-17)

= = = = = = = =
3-9-16/CC/PL: “$35-40mm and today, we believe we can exceed this guidance and top $40mm in contract mfg. revenues for the full FY'16.”
ACTUAL FY16= $44.4mm (reported 7-14-16)

3-12-15/CC/PL: “raising our contract mfg. revenue guidance to $23-25mm for the full FY’15.”
ACTUAL FY15= $26.7mm (reported 7-14-15)

3-7-14/CC/PL: “maintaining our initial contract mfg. revenue guidance of $18-22mm for the entire FY'14, and we are on track to hit the higher end of that range.”
ACTUAL FY14= $22.3mm (reported 7-14-14)

3-12-13/CC/PL: “we’re raising revenue guidance from for the entire FY’13 to at least $20mm.”
ACTUAL FY14= $21.3mm (reported 7-11-13)

AVID REVS TABLE THRU 1-30-17 (FY17/Q3):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129479667